$TNXP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Tonix Pharmaceuticals Holding Corp..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Tonix Pharmaceuticals Holding Corp.. Get notifications about new insider transactions in Tonix Pharmaceuticals Holding Corp. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 26 2021 | TNXP | Tonix Pharmaceutic ... | Goodman Daniel Wintner | Director | Buy | P | 1.12 | 5,000 | 5,600 | 5,001 | 1 to 5 K (+500,000.00 %) |
May 12 2021 | TNXP | Tonix Pharmaceutic ... | Treco James | Director | Option Exercise | A | 1.03 | 270,882 | 279,008 | 270,882 | |
May 12 2021 | TNXP | Tonix Pharmaceutic ... | Treco James | Director | Option Exercise | A | 1.03 | 270,882 | 279,008 | 270,882 | |
May 12 2021 | TNXP | Tonix Pharmaceutic ... | OLUKOTUN ADEOYE Y | Director | Option Exercise | A | 1.03 | 270,882 | 279,008 | 270,882 | |
May 12 2021 | TNXP | Tonix Pharmaceutic ... | OLUKOTUN ADEOYE Y | Director | Option Exercise | A | 1.03 | 270,882 | 279,008 | 270,882 | |
May 12 2021 | TNXP | Tonix Pharmaceutic ... | GRANGE DAVID L | Director | Option Exercise | A | 1.03 | 270,882 | 279,008 | 270,882 | |
May 12 2021 | TNXP | Tonix Pharmaceutic ... | Goodman Daniel Wintner | Director | Option Exercise | A | 1.03 | 270,882 | 279,008 | 270,882 | |
May 12 2021 | TNXP | Tonix Pharmaceutic ... | GRANGE DAVID L | Director | Option Exercise | A | 1.03 | 270,882 | 279,008 | 270,882 | |
May 12 2021 | TNXP | Tonix Pharmaceutic ... | Bell Margaret Smith | Director | Option Exercise | A | 1.03 | 270,882 | 279,008 | 270,882 | |
May 12 2021 | TNXP | Tonix Pharmaceutic ... | Goodman Daniel Wintner | Director | Option Exercise | A | 1.03 | 270,882 | 279,008 | 270,882 | |
May 12 2021 | TNXP | Tonix Pharmaceutic ... | Bell Margaret Smith | Director | Option Exercise | A | 1.03 | 270,882 | 279,008 | 270,882 | |
May 12 2021 | TNXP | Tonix Pharmaceutic ... | BAGGER RICHARD H | Director | Option Exercise | A | 1.03 | 270,882 | 279,008 | 270,882 | |
May 12 2021 | TNXP | Tonix Pharmaceutic ... | BAGGER RICHARD H | Director | Option Exercise | A | 1.03 | 270,882 | 279,008 | 270,882 | |
Feb 25 2021 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 1.53 | 540,000 | 826,200 | 540,000 | |
Feb 25 2021 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 1.22 | 540,000 | 658,800 | 540,000 | |
Feb 25 2021 | TNXP | Tonix Pharmaceutic ... | MORRIS JESSICA EDGAR | Chief Operating Off ... | Option Exercise | A | 1.53 | 540,000 | 826,200 | 540,000 | |
Feb 25 2021 | TNXP | Tonix Pharmaceutic ... | MORRIS JESSICA EDGAR | Chief Operating Off ... | Option Exercise | A | 1.22 | 540,000 | 658,800 | 540,000 | |
Feb 25 2021 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 1.53 | 750,000 | 1,147,500 | 750,000 | |
Feb 25 2021 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 1.22 | 750,000 | 915,000 | 750,000 | |
Feb 25 2021 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Grant | A | 0.51 | 41,322 | 21,074 | 62,727 | 21.4 K to 62.7 K (+193.05 %) |
Jan 04 2021 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 0.68 | 35,000 | 23,800 | 118,267 | 83.3 K to 118.3 K (+42.03 %) |
Sep 01 2020 | TNXP | Tonix Pharmaceutic ... | Treco James | Director | Buy | P | 0.89 | 5,500 | 4,895 | 10,000 | 4.5 K to 10 K (+122.22 %) |
Aug 24 2020 | TNXP | Tonix Pharmaceutic ... | Bell Margaret Smith | Director | Buy | P | 0.93 | 5,391 | 4,997 | 5,391 | 0 to 5.4 K |
Aug 19 2020 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Buy | P | 1.03 | 20,000 | 20,600 | 21,405 | 1.4 K to 21.4 K (+1,423.49 %) |
Aug 17 2020 | TNXP | Tonix Pharmaceutic ... | Treco James | Director | Buy | P | 1.06 | 4,500 | 4,770 | 4,500 | 0 to 4.5 K |
Aug 17 2020 | TNXP | Tonix Pharmaceutic ... | OLUKOTUN ADEOYE Y | Director | Buy | P | 0.94 | 5,350 | 5,029 | 5,350 | 0 to 5.4 K |
Aug 17 2020 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 0.91 | 60,000 | 54,600 | 83,267 | 23.3 K to 83.3 K (+257.88 %) |
Aug 17 2020 | TNXP | Tonix Pharmaceutic ... | BAGGER RICHARD H | Director | Buy | P | 0.91 | 10,000 | 9,100 | 10,000 | 0 to 10 K |
Jun 11 2020 | TNXP | Tonix Pharmaceutic ... | BAGGER RICHARD H | Director | Option Exercise | A | 0.71 | 68,750 | 48,813 | 68,750 | |
May 06 2020 | TNXP | Tonix Pharmaceutic ... | Bell Margaret Smith | Director | Option Exercise | A | 0.77 | 75,000 | 57,750 | 75,000 | |
May 06 2020 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Option Exercise | A | 0.77 | 75,000 | 57,750 | 75,000 | |
May 06 2020 | TNXP | Tonix Pharmaceutic ... | GRANGE DAVID L | Director | Option Exercise | A | 0.00 | 75,000 | 0 | 75,000 | |
May 06 2020 | TNXP | Tonix Pharmaceutic ... | Treco James | Director | Option Exercise | A | 0.77 | 112,500 | 86,625 | 112,500 | |
May 06 2020 | TNXP | Tonix Pharmaceutic ... | Goodman Daniel Wintner | Director | Option Exercise | A | 0.77 | 75,000 | 57,750 | 75,000 | |
May 06 2020 | TNXP | Tonix Pharmaceutic ... | OLUKOTUN ADEOYE Y | Director | Option Exercise | A | 0.77 | 75,000 | 57,750 | 75,000 | |
May 06 2020 | TNXP | Tonix Pharmaceutic ... | MORRIS JESSICA EDGAR | Chief Operating Off ... | Option Exercise | A | 0.96 | 360,000 | 345,600 | 360,000 | |
May 06 2020 | TNXP | Tonix Pharmaceutic ... | MORRIS JESSICA EDGAR | Chief Operating Off ... | Option Exercise | A | 0.77 | 360,000 | 277,200 | 360,000 | |
May 06 2020 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 0.96 | 360,000 | 345,600 | 360,000 | |
May 06 2020 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 0.77 | 360,000 | 277,200 | 360,000 | |
May 06 2020 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 0.96 | 500,000 | 480,000 | 500,000 | |
May 06 2020 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 0.77 | 500,000 | 385,000 | 500,000 | |
May 06 2020 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 0.96 | 2,000,000 | 1,920,000 | 2,000,000 | |
May 06 2020 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 0.77 | 2,000,000 | 1,540,000 | 2,000,000 | |
Mar 18 2020 | TNXP | Tonix Pharmaceutic ... | Treco James | Director | Option Exercise | A | 0.53 | 6,000 | 3,180 | 6,000 | |
Feb 27 2020 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 0.50 | 24,000 | 12,000 | 24,000 | |
Feb 27 2020 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 0.40 | 24,000 | 9,600 | 24,000 | |
Feb 27 2020 | TNXP | Tonix Pharmaceutic ... | MORRIS JESSICA EDGAR | Chief Operating Off ... | Option Exercise | A | 0.50 | 24,000 | 12,000 | 24,000 | |
Feb 27 2020 | TNXP | Tonix Pharmaceutic ... | MORRIS JESSICA EDGAR | Chief Operating Off ... | Option Exercise | A | 0.40 | 24,000 | 9,600 | 24,000 | |
Dec 04 2019 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 1.16 | 20,000 | 23,180 | 23,267 | 3.3 K to 23.3 K (+612.18 %) |
May 08 2019 | TNXP | Tonix Pharmaceutic ... | Goodman Daniel Wintner | Director | Option Exercise | A | 2.05 | 30,000 | 61,500 | 30,000 | |
May 08 2019 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 2.56 | 129,757 | 332,178 | 129,757 | |
May 08 2019 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 2.05 | 129,758 | 266,004 | 129,758 | |
May 08 2019 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 2.56 | 43,252 | 110,725 | 43,252 | |
May 08 2019 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 2.05 | 43,253 | 88,669 | 43,253 | |
May 08 2019 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 2.56 | 28,835 | 73,818 | 28,835 | |
May 08 2019 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 2.05 | 28,835 | 59,112 | 28,835 | |
May 08 2019 | TNXP | Tonix Pharmaceutic ... | MORRIS JESSICA EDGAR | Chief Operating Off ... | Option Exercise | A | 2.56 | 28,835 | 73,818 | 28,835 | |
May 08 2019 | TNXP | Tonix Pharmaceutic ... | MORRIS JESSICA EDGAR | Chief Operating Off ... | Option Exercise | A | 2.05 | 28,835 | 59,112 | 28,835 | |
May 08 2019 | TNXP | Tonix Pharmaceutic ... | LANDRY DONALD W | Director | Option Exercise | A | 2.05 | 30,000 | 61,500 | 30,000 | |
May 08 2019 | TNXP | Tonix Pharmaceutic ... | GRANGE DAVID L | Director | Option Exercise | A | 2.05 | 30,000 | 61,500 | 30,000 | |
May 08 2019 | TNXP | Tonix Pharmaceutic ... | GRACE PATRICK P | Director | Option Exercise | A | 2.05 | 30,000 | 61,500 | 30,000 | |
May 08 2019 | TNXP | Tonix Pharmaceutic ... | OLUKOTUN ADEOYE Y | Director | Option Exercise | A | 2.05 | 30,000 | 61,500 | 30,000 | |
May 08 2019 | TNXP | Tonix Pharmaceutic ... | Treco James | Director | Option Exercise | A | 2.05 | 30,000 | 61,500 | 30,000 | |
May 08 2019 | TNXP | Tonix Pharmaceutic ... | Bell Margaret Smith | Director | Option Exercise | A | 2.05 | 30,000 | 61,500 | 30,000 | |
May 08 2019 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Option Exercise | A | 2.05 | 45,000 | 92,250 | 45,000 | |
Apr 01 2019 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 2.49 | 5,000 | 12,440 | 32,670 | 27.7 K to 32.7 K (+18.07 %) |
Mar 28 2019 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 2.38 | 25,000 | 59,375 | 27,670 | 2.7 K to 27.7 K (+936.33 %) |
Feb 27 2019 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 2.36 | 5,170 | 12,201 | 5,170 | |
Feb 27 2019 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 1.89 | 5,170 | 9,771 | 5,170 | |
Feb 27 2019 | TNXP | Tonix Pharmaceutic ... | MORRIS JESSICA EDGAR | Chief Operating Off ... | Option Exercise | A | 2.36 | 5,170 | 12,201 | 5,170 | |
Feb 27 2019 | TNXP | Tonix Pharmaceutic ... | MORRIS JESSICA EDGAR | Chief Operating Off ... | Option Exercise | A | 1.89 | 5,170 | 9,771 | 5,170 | |
Feb 27 2019 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 2.36 | 7,755 | 18,302 | 7,755 | |
Feb 27 2019 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 1.89 | 7,755 | 14,657 | 7,755 | |
Feb 27 2019 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 2.36 | 23,265 | 54,905 | 23,265 | |
Feb 27 2019 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 1.89 | 23,265 | 43,971 | 23,265 | |
Feb 19 2019 | TNXP | Tonix Pharmaceutic ... | Treco James | Director | Option Exercise | A | 1.86 | 10,000 | 18,600 | 10,000 | |
Sep 07 2018 | TNXP | Tonix Pharmaceutic ... | OLUKOTUN ADEOYE Y | Director | Option Exercise | A | 1.03 | 15,000 | 15,450 | 15,000 | |
Jul 02 2018 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 4.64 | 500 | 2,320 | 17,666 | 17.2 K to 17.7 K (+2.91 %) |
Jun 29 2018 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 4.58 | 500 | 2,290 | 17,166 | 16.7 K to 17.2 K (+3.00 %) |
Jun 28 2018 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 4.55 | 500 | 2,275 | 16,666 | 16.2 K to 16.7 K (+3.09 %) |
Jun 27 2018 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Buy | P | 4.48 | 16,500 | 73,920 | 50,000 | 33.5 K to 50 K (+49.25 %) |
Jun 15 2018 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Buy | P | 3.97 | 10,000 | 39,650 | 20,482 | 10.5 K to 20.5 K (+95.40 %) |
Jun 14 2018 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 4.37 | 2,000 | 8,740 | 20,463 | 18.5 K to 20.5 K (+10.83 %) |
Jun 14 2018 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 4.37 | 1,000 | 4,370 | 16,166 | 15.2 K to 16.2 K (+6.59 %) |
Jun 14 2018 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Buy | P | 4.10 | 300 | 1,230 | 3,079 | 2.8 K to 3.1 K (+10.80 %) |
Jun 14 2018 | TNXP | Tonix Pharmaceutic ... | MORRIS JESSICA EDGAR | Chief Operating Off ... | Buy | P | 4.19 | 300 | 1,257 | 1,638 | 1.3 K to 1.6 K (+22.42 %) |
Jun 13 2018 | TNXP | Tonix Pharmaceutic ... | GRACE PATRICK P | Director | Option Exercise | A | 4.25 | 20,000 | 85,000 | 20,000 | |
Jun 13 2018 | TNXP | Tonix Pharmaceutic ... | GRANGE DAVID L | Director | Option Exercise | A | 4.25 | 20,000 | 85,000 | 20,000 | |
Jun 13 2018 | TNXP | Tonix Pharmaceutic ... | LANDRY DONALD W | Director | Option Exercise | A | 4.25 | 20,000 | 85,000 | 20,000 | |
Jun 13 2018 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Option Exercise | A | 4.25 | 20,000 | 85,000 | 20,000 | |
Jun 13 2018 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Option Exercise | A | 4.25 | 20,000 | 85,000 | 20,000 | |
Jun 13 2018 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Option Exercise | A | 4.25 | 30,000 | 127,500 | 30,000 | |
Jun 13 2018 | TNXP | Tonix Pharmaceutic ... | Bell Margaret Smith | Director | Option Exercise | A | 4.25 | 20,000 | 85,000 | 20,000 | |
Jun 13 2018 | TNXP | Tonix Pharmaceutic ... | Saks Samuel R | Director | Option Exercise | A | 4.25 | 20,000 | 85,000 | 20,000 | |
Jun 06 2018 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Buy | P | 3.33 | 7,500 | 24,975 | 23,470 | 16 K to 23.5 K (+46.96 %) |
May 30 2018 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 3.17 | 4,000 | 12,680 | 26,700 | 22.7 K to 26.7 K (+17.62 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | Saks Samuel R | Director | Option Exercise | M | 0.00 | 650 | 0 | 0 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | Saks Samuel R | Director | Option Exercise | M | 0.00 | 750 | 0 | 0 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | Saks Samuel R | Director | Option Exercise | M | 0.00 | 750 | 0 | 0 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | Saks Samuel R | Director | Buy | M | 0.00 | 600 | 0 | 3,855 | 3.3 K to 3.9 K (+18.43 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | Saks Samuel R | Director | Buy | M | 0.00 | 750 | 0 | 5,855 | 5.1 K to 5.9 K (+14.69 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | Saks Samuel R | Director | Buy | M | 0.00 | 750 | 0 | 6,605 | 5.9 K to 6.6 K (+12.81 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | GRACE PATRICK P | Director | Option Exercise | M | 0.00 | 600 | 0 | 0 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | GRACE PATRICK P | Director | Option Exercise | M | 0.00 | 750 | 0 | 0 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | GRACE PATRICK P | Director | Option Exercise | M | 0.00 | 750 | 0 | 0 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | GRACE PATRICK P | Director | Buy | M | 0.00 | 600 | 0 | 1,255 | 655 to 1.3 K (+91.60 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | GRACE PATRICK P | Director | Buy | M | 0.00 | 750 | 0 | 2,005 | 1.3 K to 2 K (+59.76 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | GRACE PATRICK P | Director | Buy | M | 0.00 | 750 | 0 | 2,755 | 2 K to 2.8 K (+37.41 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | LANDRY DONALD W | Director | Option Exercise | M | 0.00 | 600 | 0 | 0 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | LANDRY DONALD W | Director | Option Exercise | M | 0.00 | 750 | 0 | 0 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | LANDRY DONALD W | Director | Option Exercise | M | 0.00 | 750 | 0 | 0 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | LANDRY DONALD W | Director | Buy | M | 0.00 | 600 | 0 | 7,710 | 7.1 K to 7.7 K (+8.44 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | LANDRY DONALD W | Director | Buy | M | 0.00 | 750 | 0 | 8,460 | 7.7 K to 8.5 K (+9.73 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | LANDRY DONALD W | Director | Buy | M | 0.00 | 750 | 0 | 9,210 | 8.5 K to 9.2 K (+8.87 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Option Exercise | M | 0.00 | 600 | 0 | 0 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Option Exercise | M | 0.00 | 750 | 0 | 0 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Option Exercise | M | 0.00 | 750 | 0 | 0 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Buy | M | 0.00 | 600 | 0 | 26,648 | 26 K to 26.6 K (+2.30 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Buy | M | 0.00 | 750 | 0 | 63,822 | 63.1 K to 63.8 K (+1.19 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Buy | M | 0.00 | 750 | 0 | 64,572 | 63.8 K to 64.6 K (+1.18 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Gift | G | 0.00 | 10,000 | 0 | 33,500 | 23.5 K to 33.5 K (+42.55 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Gift | G | 0.00 | 10,000 | 0 | 0 | 10 K to 0 (-100.00 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Option Exercise | M | 0.00 | 600 | 0 | 0 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Option Exercise | M | 0.00 | 1,125 | 0 | 0 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Option Exercise | M | 0.00 | 1,125 | 0 | 0 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Buy | M | 0.00 | 600 | 0 | 8,720 | 8.1 K to 8.7 K (+7.39 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Buy | M | 0.00 | 1,125 | 0 | 14,845 | 13.7 K to 14.8 K (+8.20 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | Rhodes John B | Director | Buy | M | 0.00 | 1,125 | 0 | 15,970 | 14.8 K to 16 K (+7.58 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Option Exercise | M | 0.00 | 600 | 0 | 0 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Option Exercise | M | 0.00 | 750 | 0 | 0 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Option Exercise | M | 0.00 | 750 | 0 | 0 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Buy | M | 0.00 | 600 | 0 | 1,783 | 1.2 K to 1.8 K (+50.72 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Buy | M | 0.00 | 750 | 0 | 2,533 | 1.8 K to 2.5 K (+42.06 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Buy | M | 0.00 | 750 | 0 | 3,283 | 2.5 K to 3.3 K (+29.61 %) |
Feb 15 2018 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 4.25 | 58,725 | 249,581 | 58,725 | |
Feb 15 2018 | TNXP | Tonix Pharmaceutic ... | SULLIVAN GREGORY M | Chief Medical Offic ... | Option Exercise | A | 3.40 | 58,726 | 199,668 | 58,726 | |
Feb 15 2018 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 4.25 | 156,601 | 665,554 | 156,601 | |
Feb 15 2018 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 3.40 | 156,601 | 532,443 | 156,601 | |
Feb 15 2018 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 4.25 | 39,150 | 166,388 | 39,150 | |
Feb 15 2018 | TNXP | Tonix Pharmaceutic ... | SAENGER BRADLEY | Chief Financial Off ... | Option Exercise | A | 3.40 | 39,150 | 133,110 | 39,150 | |
Feb 15 2018 | TNXP | Tonix Pharmaceutic ... | MORRIS JESSICA EDGAR | Chief Operating Off ... | Option Exercise | A | 4.25 | 39,150 | 166,388 | 39,150 | |
Feb 15 2018 | TNXP | Tonix Pharmaceutic ... | MORRIS JESSICA EDGAR | Chief Operating Off ... | Option Exercise | A | 3.40 | 39,150 | 133,110 | 39,150 | |
Feb 15 2018 | TNXP | Tonix Pharmaceutic ... | GRANGE DAVID L | Director | Option Exercise | A | 3.40 | 7,000 | 23,800 | 7,000 | |
Dec 27 2017 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 3.61 | 5,300 | 19,133 | 22,700 | 17.4 K to 22.7 K (+30.46 %) |
Dec 22 2017 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Sell | S | 3.46 | 5,000 | 17,300 | 23,500 | 28.5 K to 23.5 K (-17.54 %) |
Dec 22 2017 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Sell | S | 3.44 | 8,965 | 30,840 | 28,500 | 37.5 K to 28.5 K (-23.93 %) |
Dec 22 2017 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Sell | S | 3.51 | 6,035 | 21,183 | 37,465 | 43.5 K to 37.5 K (-13.87 %) |
Dec 22 2017 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Sell | S | 3.57 | 10,000 | 35,700 | 43,500 | 53.5 K to 43.5 K (-18.69 %) |
Dec 22 2017 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Sell | S | 3.55 | 5,000 | 17,750 | 53,500 | 58.5 K to 53.5 K (-8.55 %) |
Dec 22 2017 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Sell | S | 3.58 | 1,967 | 7,042 | 55,467 | 57.4 K to 55.5 K (-3.42 %) |